Equities

Fusen Pharmaceutical Co Ltd

Fusen Pharmaceutical Co Ltd

Actions
  • Price (HKD)1.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-28.57%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments3613382
Total Receivables, Net328311259
Total Inventory162111122
Prepaid expenses413947
Other current assets, total020--
Total current assets567614509
Property, plant & equipment, net562530506
Goodwill, net------
Intangibles, net230.480.68
Long term investments164195216
Note receivable - long term------
Other long term assets236.102.10
Total assets1,3441,3501,239
LIABILITIES
Accounts payable168164102
Accrued expenses109121120
Notes payable/short-term debt0150141
Current portion long-term debt/capital leases2387822
Other current liabilities, total150209105
Total current liabilities665722489
Total long term debt1060.4378
Total debt344228241
Deferred income tax0.303.544.68
Minority interest(1.29)(1.27)(1.23)
Other liabilities, total101111
Total liabilities780736581
SHAREHOLDERS EQUITY
Common stock6.316.386.48
Additional paid-in capital231247259
Retained earnings (accumulated deficit)311346378
Treasury stock - common(0.08)(0.05)(0.04)
Unrealized gain (loss)------
Other equity, total151514
Total equity564614658
Total liabilities & shareholders' equity1,3441,3501,239
Total common shares outstanding750758765
Treasury shares - common primary issue005.11
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.